TickerFacts.

Gain Therapeutics, Inc. (GANX): Revenue

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Revenue is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$55.2K
Year ended 2023-12-31
+24.1%
3-year compound annual growth
$165.0K2020-12-31: $28.9K2021-12-31: $165.0K2022-12-31: $140.1K2023-12-31: $55.2K$55.2K
2020-12-31 Revenue (USD) 2023-12-31
Period endedRevenueChange YoYSource filing
2023-12-31$55.2K-60.6%2025-03-27, From 2023-01-01
2022-12-31$140.1K-15.1%2024-03-26, From 2022-01-01
2021-12-31$165.0K+471.3%2023-03-23, From 2021-01-01
2020-12-31$28.9Kn/a2022-03-25, From 2020-01-01